Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
19 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Easton Pharmaceuticals Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Easton Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Easton Pharmaceuticals Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Easton Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Easton Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Easton Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Easton Pharmaceuticals Inc.'s pipeline products Reasons to buy - Evaluate Easton Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Easton Pharmaceuticals Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Easton Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Easton Pharmaceuticals Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Easton Pharmaceuticals Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Easton Pharmaceuticals Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Easton Pharmaceuticals Inc. Snapshot 4 Easton Pharmaceuticals Inc. Overview 4 Key Information 4 Key Facts 4 Easton Pharmaceuticals Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Easton Pharmaceuticals Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Easton Pharmaceuticals Inc. - Pipeline Products Glance 9 Easton Pharmaceuticals Inc. - Early Stage Pipeline Products 9 Preclinical Products/Combination Treatment Modalities 9 Discovery Products/Combination Treatment Modalities 10 Easton Pharmaceuticals Inc. - Drug Profiles 11 EP-003 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 Xilive 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 EP-004 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 EP-005 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Easton Pharmaceuticals Inc. - Pipeline Analysis 15 Easton Pharmaceuticals Inc. - Pipeline Products by Route of Administration 15 Easton Pharmaceuticals Inc. - Recent Pipeline Updates 16 Easton Pharmaceuticals Inc. - Locations And Subsidiaries 17 Head Office 17 Appendix 18 Methodology 18 Coverage 18 Secondary Research 18 Primary Research 18 Expert Panel Validation 18 Contact Us 19 Disclaimer 19
List of Tables Easton Pharmaceuticals Inc., Key Information 4 Easton Pharmaceuticals Inc., Key Facts 4 Easton Pharmaceuticals Inc. - Pipeline by Indication, 2014 6 Easton Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 7 Easton Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 8 Easton Pharmaceuticals Inc. - Preclinical, 2014 9 Easton Pharmaceuticals Inc. - Discovery, 2014 10 Easton Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014 15 Easton Pharmaceuticals Inc. - Recent Pipeline Updates, 2014 16
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.